Genomed (WAR:GEN) Moat Score: 0/10 (As of Jul. 03, 2026)


WAR:GEN Genomed SA WAR:GEN
74 GF Score
Price zł29.00
GF Value zł37.86
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Genomed Moat Score?

Genomed has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Genomed has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Genomed might have No Moat - No discernible moat.

Genomed  (WAR:GEN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Genomed Moat Score Related Terms

WAR:GEN
74GF Score
Genomed SA WAR:GEN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genomed (WAR:GEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genomed stock appears to be undervalued. The current stock price of zł29.00 is trading 23.4% below its estimated GF Value™ of zł37.86. GuruFocus considers Genomed to be Modestly Undervalued.

Key valuation signals for WAR:GEN:

  • Moat Score: 0
  • GF Value™: zł37.86 vs. price of zł29.00 (23.4% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the WAR:GEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomed Business Description

Address Ulica Ponczowa 12, Warszawa, POL, 02-971
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
74GF Score

Get the complete analysis for WAR:GEN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł29.00
Price
zł37.86
GF Value